**This Weight-Loss Solution is Now India’s Second-Highest Selling Drug**
*By Dwaipayan Roy | Oct 08, 2025, 05:14 PM*
Eli Lilly’s anti-obesity and diabetes drug, **Mounjaro**, has taken the Indian pharmaceutical market by storm. Remarkably, the drug has become the second-best selling medication in India within just six months of its launch. This surge comes amid a growing demand for effective weight-loss therapies across the country.
### Market Performance: Mounjaro’s Sales Soar
According to data from the Indian Pharmaceutical Market (IPM), Mounjaro recorded sales worth ₹80 crore in September alone, contributing to a total revenue of ₹233 crore since its debut. The drug experienced an impressive 43% sales growth from August to September, challenging the market leader GSK’s Augmentin, which currently holds retail monthly sales of ₹85 crore.
Industry analysts attribute Mounjaro’s rapid success largely to its user-friendly pen formulation, which has resonated well with patients. Additionally, recent reductions in the Goods and Services Tax (GST) are expected to further accelerate its sales momentum in the upcoming months.
### Product Details: High Efficacy and Convenient Usage
Launched in late March, Mounjaro offers weight-loss efficacy in the range of **20-22%**, making it a highly effective therapy option. The introduction of its injectable Kwikpens in August gave a significant boost to its sales. These disposable pens are pre-filled with the medication and are available in dosages priced between ₹14,000 and ₹27,500, depending on the strength.
### Sales Forecast: Impact of GST Cuts
A major factor contributing to the rising adoption of Mounjaro is the recent GST reduction from 18% to 5%, effective from September 22. This tax cut has substantially eased the financial burden on patients requiring chronic care medications, including those for weight management.
With better affordability and continuous demand, Mounjaro’s sales are expected to maintain strong growth, further solidifying its position in the Indian pharmaceutical market.
—
*Stay tuned for more updates on Mounjaro and other breakthrough therapies transforming healthcare in India.*
https://www.newsbytesapp.com/news/business/eli-lilly-s-mounjaro-becomes-2nd-best-selling-drug-in-india/story
